Nesvacumab: Difference between revisions
Content deleted Content added
m Identifier not assigned: use =none (CAS RN, ChemSpider, ATC) (via AWB script) |
m molar weight unit in g/mol (via AWB script) |
||
| Line 31: | Line 31: | ||
| ChemSpiderID = none |
| ChemSpiderID = none |
||
| C=6440 | H=9966 | N=1722 | O=2008 | S=38 |
| C=6440 | H=9966 | N=1722 | O=2008 | S=38 |
||
| molecular_weight |
| molecular_weight = 144.9 kg/mol |
||
}} |
}} |
||
'''Nesvacumab''' is a monoclonal antibody designed for the treatment of cancer.<ref>[http://www.ama-assn.org/resources/doc/usan/nesvacumab.pdf Statement On A Nonproprietary Name Adopted By The USAN Council - Nesvacumab], ''[[American Medical Association]]''.</ref> |
'''Nesvacumab''' is a monoclonal antibody designed for the treatment of cancer.<ref>[http://www.ama-assn.org/resources/doc/usan/nesvacumab.pdf Statement On A Nonproprietary Name Adopted By The USAN Council - Nesvacumab], ''[[American Medical Association]]''.</ref> |
||
Revision as of 15:34, 28 February 2016
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Human |
| Target | angiopoietin 2 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| IUPHAR/BPS | |
| ChemSpider |
|
| Chemical and physical data | |
| Formula | C6440H9966N1722O2008S38 |
| Molar mass | 144.9 kg/mol g·mol−1 |
Nesvacumab is a monoclonal antibody designed for the treatment of cancer.[1]
This drug was developed by Regeneron Pharmaceuticals.
References
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |